Eklira Genuair

Eklira Genuair is an inhalation medication containing aclidinium bromide, used for managing chronic obstructive pulmonary disease (COPD). This maintenance bronchodilator helps improve breathing by relaxing airway muscles.

Eklira Genuair is primarily used for the long-term management of chronic obstructive pulmonary disease (COPD). This medication works by relaxing the muscles in the airways, making it easier to breathe. It is not intended for immediate relief of sudden breathing problems but is used regularly to maintain lung function.

Common effects of Eklira Genuair may include dry mouth, throat irritation, and cough. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

Eklira Genuair should be used as directed and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart problems or glaucoma, should consult a healthcare provider before use.

Eklira Genuair may interact with other medications, including anticholinergics and beta-blockers. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.